HCPCS codes / S / S2107
S2107
Adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g., tumor-infiltrating lymphocyte therapy) per course of treatment
- Code type
- HCPCS Level II
- Coverage
- Not payable by Medicare
- BETOS category
- Z2
- Pricing indicator
- 00
- Effective date
- 20020401
Verify before billing. Confirm against current official CMS HCPCS files and your payer's rules before clinical or claims use.